investorscraft@gmail.com

Intrinsic Value3D Systems Corporation (SYV.DE)

Previous Close1.93
Intrinsic Value
Upside potential
Previous Close
1.93

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

3D Systems Corporation operates in the computer hardware sector, specializing in 3D printing and digital manufacturing solutions. The company serves a diverse range of industries, including medical, aerospace, automotive, and consumer goods, through its portfolio of 3D printers, materials, and software. Its offerings span stereolithography, selective laser sintering, and bioprinting technologies, supported by proprietary software like 3D Sprint and Geomagic for design optimization and workflow management. 3D Systems holds a competitive position in the additive manufacturing market, leveraging its extensive product ecosystem and direct sales channels. The company’s focus on precision healthcare and industrial applications differentiates it from generalist competitors, though it faces intense competition from both established players and emerging innovators. Its global footprint, with operations across the Americas, Europe, and Asia Pacific, provides access to key growth markets, but execution risks remain amid rapid technological advancements and shifting customer demands.

Revenue Profitability And Efficiency

For FY 2024, 3D Systems reported revenue of €440.1 million, reflecting its broad industrial and healthcare customer base. However, the company posted a net loss of €255.6 million, with diluted EPS of -€1.94, indicating ongoing profitability challenges. Operating cash flow was negative at €44.9 million, exacerbated by capital expenditures of €16.1 million, underscoring inefficiencies in converting revenue to cash.

Earnings Power And Capital Efficiency

The company’s negative earnings and cash flow highlight struggles in achieving sustainable profitability. High R&D and operational costs, coupled with competitive pricing pressures, have eroded margins. Capital efficiency remains weak, as evidenced by the disparity between revenue growth and cash burn, though its €171.3 million cash reserve provides near-term liquidity.

Balance Sheet And Financial Health

3D Systems maintains a mixed balance sheet, with €171.3 million in cash and equivalents against €286.1 million in total debt. The net debt position raises concerns about leverage, though the absence of dividends allows for reinvestment. The company’s liquidity position is adequate for now, but sustained losses could strain financial flexibility.

Growth Trends And Dividend Policy

Revenue trends suggest moderate demand, but profitability remains elusive. The company does not pay dividends, prioritizing growth initiatives and debt management. Long-term success hinges on scaling high-margin segments like healthcare and software, though execution risks persist.

Valuation And Market Expectations

With a market cap of €193 million and a beta of 1.95, 3D Systems is viewed as a high-risk, high-reward play in additive manufacturing. Investors appear skeptical of its turnaround potential, given persistent losses and competitive headwinds. Valuation multiples reflect subdued expectations until profitability improves.

Strategic Advantages And Outlook

3D Systems benefits from its diversified product suite and stronghold in niche markets like bioprinting. However, operational inefficiencies and macroeconomic uncertainties cloud its outlook. Strategic partnerships or M&A could bolster its position, but organic growth must accelerate to justify its risk profile.

Sources

Company filings, market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount